Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.62%
0%
-0.62%
6 Months
-11.6%
0%
-11.6%
1 Year
-14.44%
0%
-14.44%
2 Years
-44.35%
0%
-44.35%
3 Years
-41.82%
0%
-41.82%
4 Years
-53.96%
0%
-53.96%
5 Years
-64.44%
0%
-64.44%
Predilife SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.07%
EBIT Growth (5y)
-6.73%
EBIT to Interest (avg)
-4.11
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.12
Tax Ratio
4.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.90
EV to EBIT
-3.83
EV to EBITDA
-3.86
EV to Capital Employed
-1.60
EV to Sales
15.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.30
0.30
Operating Profit (PBDIT) excl Other Income
-3.80
-3.50
-8.57%
Interest
0.00
0.30
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.20
-3.70
-13.51%
Operating Profit Margin (Excl OI)
-12,102.70%
-12,193.60%
9.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 0.00% vs 200.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -13.51% vs -8.82% in Dec 2022
About Predilife SA 
Predilife SA
Software Products
Predilife SA is a France-based company specialized in the development of predictive tests in the medical industry. The Company operates mainly in the field of oncology. Predilife offers MammoRisk, which is a predictive breast cancer test that combines medical imaging thanks to a proprietary software, DenSeeMammo, Big Data and statistics through a scoring tool and genetic profiles via a polygenic risk score (PRS). The image is analysed in order to extract the breast density and the first breast cancer risk factor. In addition, The technology used by MammoRisk makes it possible to evaluate from a database of individuals tracked over time, the risks of an individual to develop cancer compared to the fate of his/her closest neighbors through a database of a number of American and French women.
Company Coordinates 
Company Details
114 Rue Edouard Vaillant , VILLEJUIF None : 94800
Registrar Details






